(3S)-1-(Tert-Butoxycarbonyl)-3-Pyrrolidinecarboxylic Acid

(3S)-1-(Tert-Butoxycarbonyl)-3-Pyrrolidinecarboxylic Acid


    • Product Name (3S)-1-(Tert-Butoxycarbonyl)-3-Pyrrolidinecarboxylic Acid
    • Alias Boc-L-Pro-OH
    • Einecs 426-070-6
    • Mininmum Order 1 Gram
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    309923

    Chemical Formula C10H17NO4
    Molar Mass 215.246 g/mol
    Appearance White to off - white solid
    Solubility In Water Poorly soluble
    Solubility In Organic Solvents Soluble in common organic solvents like dichloromethane, ethyl acetate
    Melting Point 110 - 114 °C
    Chirality Optically active, (3S) - configuration
    Functional Groups Carboxylic acid, tert - butoxycarbonyl, pyrrolidine ring
    Pka Carboxylic Acid Around 3 - 4
    Stability Stable under normal conditions, but sensitive to strong acids and bases

    As an accredited (3S)-1-(Tert-Butoxycarbonyl)-3-Pyrrolidinecarboxylic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 500g of (3S)-1-(Tert - Butoxycarbonyl)-3 - Pyrrolidinecarboxylic Acid in sealed, labeled containers.
    Shipping (3S)-1-(tert -Butoxycarbonyl)-3-pyrrolidinecarboxylic acid is shipped with strict adherence to chemical transportation regulations. Packed securely to prevent breakage, it's sent via a carrier approved for chemical shipments, ensuring safe transit.
    Storage (3S)-1-(tert -Butoxycarbonyl)-3-pyrrolidinecarboxylic acid should be stored in a cool, dry place, away from heat sources and direct sunlight. Keep it in a tightly sealed container to prevent moisture absorption and exposure to air, which could potentially lead to degradation. Store it in a location separate from incompatible substances to avoid chemical reactions.
    Application of (3S)-1-(Tert-Butoxycarbonyl)-3-Pyrrolidinecarboxylic Acid
    Targeting the pyroglutamate mimetic motif in hepatitis C protease inhibitors, laboratory-scale coupling protocols routinely employ 1.2–1.5 eq of the Boc-pyrrolidine acid relative to the P2 amine fragment. Activation is most commonly achieved with HATU (0.98–1.02 eq) in anhydrous DMF at 0°C under argon, with DIPEA titrated to maintain apparent pH 8.5–9.0 as monitored by a Mettler Toledo InLab electrode. Atypical racemization below 0.3% ee loss has been documented when coupling temperature is held strictly below 4°C for durations under 90 min; exceeding 120 min at 8°C triggers detectable epimerization at the pyrrolidine C3 stereocenter, confirmed by chiral HPLC using a Chiralpak IA column with hexane/ethanol/TFA 80:20:0.1 mobile phase. Post-coupling deprotection with TFA/DCM 1:1—precooled to −10°C—and immediate neutralization with cold 10% K₂CO₃ has been shown to reduce diketopiperazine formation from 4.7% to 0.8% in tripeptide sequences containing glycine at the P3 site. Reaction calorimetry data from Mettler-Toledo RC1e indicate an exotherm of −145 kJ/mol during the HATU activation step, necessitating jacket temperature control at −5°C for batches exceeding 500 g. Regulatory documentation for the resulting intermediate must comply with ICH Q3A (R2) thresholds for residual DMF (class 2 solvent, PDE 8.8 mg/day) and residual TFA, which is typically controlled below 0.1% by ion chromatography per USP ⟨1055⟩.

    Directing Group Auxiliaries in Palladium-Catalyzed C–H Functionalization of Proline Scaffolds

    Installation of the Boc group on the pyrrolidine nitrogen serves a dual role when the (3S)-1-(tert-butoxycarbonyl)-3-pyrrolidinecarboxylic acid motif is employed as a transient directing group precursor. In palladium-catalyzed C(sp³)–H arylation at the C4 position, the free carboxylic acid undergoes in situ conversion to an 8-aminoquinoline amide under standard coupling conditions (HATU, Et₃N, DCM, 23°C, 18 h), after which Pd(OAc)₂ (10 mol%) and AgOAc (2.0 eq) in toluene at 110°C enable monoarylation with aryl iodides bearing electron-withdrawing substituents. The Boc group must be retained during the C–H activation step; premature cleavage under the thermal conditions—especially when traces of AcOH are present from Pd(OAc)₂—leads to irreversible catalyst poisoning by the free secondary amine, suppressing turnover numbers below 5 TON. A robust process developed from a 5‑L jacketed reactor campaign at a contract research organization mandates K₂CO₃ (0.3 eq) as acid scavenger specifically to neutralize residual acetic acid without extracting the Boc group. After arylation, the 8-aminoquinoline auxiliary is removed with BF₃·OEt₂ in MeOH/H₂O at 50°C over 16 h, and the Boc group is subsequently cleaved with HCl/dioxane for further diversification. The enantiomeric purity of the C4-arylated product has been validated by supercritical fluid chromatography (SFC) on a Chiralpak AD‑H column (CO₂/MeOH 70:30, 40°C, 150 bar), revealing >99.5% ee when the initial acid input is optically pure. Residual palladium is controlled to <10 ppm using Si‑thiol scavenger resin (Silicycle SiliaMetS) before the batch proceeds to GMP intermediate isolation.Where selectivity challenges between C2 and C4 positions arise, mechanistic probes using deuterium‑labelled substrates confirm that the Boc group steric bulk—quantified by a Taft Eₛ parameter of −1.54 for the N-Boc substituent—disfavors palladacycle formation at the C2 methylene, steering activation to the less hindered C4 site with a selectivity ratio exceeding 20:1 as measured by 1H NMR of crude reaction mixtures. This application ultimately delivers 4-aryl-substituted proline derivatives that serve as conformationally constrained building blocks for macrocyclic peptide therapeutics. ICH M7 control of potential mutagenic impurities requires monitoring of 4‑chlorophenylboronic acid by‑products when aryl chlorides are used directly; LC‑MS/MS with a limit of quantification of 1 ppm is specified.

    What Happens to Stereochemical Fidelity During Boc-Directed N-Carboxyanhydride Polymerization?

    (3S)-1-(Tert-butoxycarbonyl)-3-pyrrolidinecarboxylic acid undergoes cyclization to the corresponding N-carboxyanhydride (NCA) upon treatment with triphosgene (0.35 eq) in anhydrous THF at 50°C, facilitated by activated charcoal as HCl scavenger; the isolated NCA monomer—purified by precipitation from THF into hexane at −20°C—exhibits a melting point of 112–114°C (dec.). Ring‑opening polymerization initiated by benzylamine in DMF at 0°C with a monomer‑to‑initiator ratio of 100:1 proceeds with living character, reaching 95% conversion in 4 h as determined by FTIR monitoring of the NCA carbonyl band at 1850 cm⁻¹. The Bok group remains intact on the polymer backbone, yielding poly(proline) chains with controlled molecular weights (Mₙ 12–15 kDa, Đ 1.08–1.15 by DMF GPC calibrated with PMMA standards). Critically, the (3S) absolute configuration is fully retained throughout the NCA formation and polymerization: optical rotation measurements ([α]D²⁵) of the hydrolyzed free polyproline confirm values consistent with exclusively cis‑amide backbone geometry when DP exceeds 30, a hallmark of polyproline I helix formation. Deprotection with TFA/thioanisole (95:5, 2 h) liberates the secondary amine without chain scission, as evidenced by unchanged Mn traces. The resulting polycationic polymers have been examined as gene delivery vectors, where binding affinity to plasmid DNA—quantified by ethidium bromide exclusion assay—requires a polymer:DNA weight ratio of 3:1 for complete complexation. Regulatory considerations for such biomedical materials invoke ISO 10993‑5 cytotoxicity testing; the Boc-protected precursor polymers have demonstrated >90% cell viability in HEK293 cells at 100 µg/mL, while the fully deprotected forms require careful purification to remove residual TFA.

    When the Pyrrolidine Carboxylic Acid Becomes a Lead Component in Dipeptidyl Peptidase IV Inhibitor Backbones

    Incorporation of (3S)-1-(tert-butoxycarbonyl)-3-pyrrolidinecarboxylic acid into DPP‑IV inhibitor candidates proceeds via amide bond formation with azetidine or piperazine P2 fragments. A representative activated ester approach uses ethyl chloroformate (1.05 eq) and N-methylmorpholine (1.1 eq) in dichloromethane at −15°C to generate the mixed anhydride, which is then treated with the amine nucleophile. The rate of epimerization at the C3 stereocenter is suppressed by maintaining internal temperature below −10°C throughout the 30‑min activation window; excursion beyond −5°C results in C3 epimer content rising from 0.2% to 2.8% as quantified by validated HPLC method (Zorbax SB‑C18, 150×4.6 mm, 3.5 µm, gradient MeCN/water with 0.1% TFA). The resulting Boc‑protected intermediate is isolated by crystallization from ethyl acetate/heptane (1:4), providing product in 99.2% diastereomeric purity. Subsequent TFA‑mediated Boc removal and reductive amination with cyclopentylamine introduces the basic amine handle necessary for DPP‑IV binding interactions, as confirmed by co‑crystal structures (PDB deposition 4JWL‑like binding mode). In‑process controls for N‑nitrosamine formation became mandatory after publication of FDA guidance revision 1 in 2021: headspace GC‑MS analysis of the mixed anhydride intermediate under simulated worst‑case conditions (excess nitrite, pH 4, 50°C, 24 h) shows no detectable nitrosamine (<0.03 ppm LOQ) due to steric shielding of the pyrrolidine nitrogen by the Boc group. This attribute has become a critical selection criterion when differentiating between N‑Boc and N‑Cbz protection strategies in early development. Residual palladium from upstream hydrogenation steps is controlled to <5 ppm by charcoal filtration and confirmed by ICP‑MS before final GMP release testing per Ph. Eur. 2.4.20.

    3‑Pyrrolidinecarboxylic Acid, 1‑Boc‑Protected: Resolution Agent Screening for Chiral Amine Purification

    The rigid pyrrolidine ring and the free carboxylic acid make (3S)-1-(tert-butoxycarbonyl)-3-pyrrolidinecarboxylic acid an effective chiral resolving agent for racemic secondary amines. A salt‑resolution protocol validated on a 50‑g scale involved dissolving racemic 1‑(3‑methoxyphenyl)ethylamine (1.0 eq) and the Boc‑acid (1.0 eq) in hot 2‑propanol/water 95:5; slow cooling to 5°C over 12 h precipitates the (R)‑amine·(S)‑acid diastereomeric salt in 78% yield with 98.6% de after single recrystallization. The high discrimination is attributed to the steric interaction between the amine methyl group and the Boc‑protected nitrogen atom, as indicated by single‑crystal X‑ray diffraction data showing a close O···H‑N hydrogen bond distance of 1.89 Å in the less soluble diastereomer. Liberation of the resolved amine is accomplished with 1 M NaOH and extraction into MTBE, while the chiral acid is recovered by acidification to pH 2 and back‑extraction into ethyl acetate; recovery exceeds 92% across three cycles with negligible racemization. In GMP‑controlled manufacturing environments, the heavy metal content of the recovered resolving agent is monitored per ICH Q3D—class 1 metals (As, Pb, Cd, Hg) must each remain below 1 ppm, confirmed by inductively coupled plasma mass spectrometry. The purified chiral amine is subsequently employed in the synthesis of a selective serotonin reuptake inhibitor analogue; final API residual solvent compliance requires headspace GC determination of 2‑propanol (<5000 ppm) and MTBE (<500 ppm) per USP ⟨467⟩.Solvents commonly used in the salt resolution—methanol, isopropanol, MTBE—are subjected to daily Karl Fischer titration (limit: <0.05% water) because trace moisture reduces diastereomeric enrichment by a factor of roughly 2% per 0.1% water content, as documented during process robustness testing at −10°C to 40°C jacket temperature. This sensitivity is traced to the formation of a hydrate of the carboxylic acid which distorts crystal lattice packing. Batch records from a pilot‑plant campagin at 100‑mol input scale indicate that solution mass transfer, not nucleation kinetics, is rate‑limiting; achieving consistent de required the addition of 0.5 wt% seed crystals at 50°C during the cooling ramp. The seed crystals were prepared by anti‑solvent diffusion of heptane into a 5 wt% solution of the pure diastereomeric salt in dichloromethane and characterized by powder X‑ray diffraction to confirm Form A polymorph, which is the thermodynamically stable phase at 20°C based on Slurry Conversion experiments monitored over 7 days.

    Monitoring the Thermal Stability Window of Boc‑Pyrrolidine Acid Under Process‑Scale Vacuum Drying

    Solid‑state thermal stability data are indispensable when drying (3S)-1-(tert-butoxycarbonyl)-3-pyrrolidinecarboxylic acid after aqueous workup. Differential scanning calorimetry (DSC) at a scanning rate of 10°C/min under nitrogen atmosphere shows a broad endotherm centered at 128.5°C corresponding to melting with concomitant deprotection; however, thermogravimetric analysis–Fourier transform infrared spectroscopy (TGA‑FTIR) reveals onset of isobutylene evolution (diagnostic IR band at 890 cm⁻¹) at 105°C, with maximum rate reached at 136°C. Consequently, vacuum drying protocols at 40–45°C and <50 mbar for 16 h are standard, confirmed by loss‑on‑drying <0.5%. In a freeze‑drying process alternative—employed when the material must be stored as a lyophilized powder for long‑term cryogenic shipping—a 10% w/v solution in tert‑butanol/water 1:1 is frozen to −40°C at 0.5°C/min and primary drying conducted at −20°C and 0.1 mbar for 48 h. The resulting amorphous cake is fully reconstitutable in DMF, but exposure to atmospheric humidity above 40% RH during unloading induces rapid crystallisation to a monohydrate form that exhibits 15% lower solubility in ethyl acetate. Storage at −20°C under argon in amber HDPE containers with a desiccant bag is the established control strategy; stability data over 36 months indicate <0.1% increase in free acid impurity (N‑unprotected pyrrolidine) when these conditions are maintained. For shipments crossing tropical climate zones, active temperature logging with certified USB loggers (accuracy ±0.5°C) and inclusion of 50 g silica gel per 1 kg of material form part of the release documentation submitted to the importing country's customs authority.
    Table 1. Comparative Thermogravimetric Data for Batch Drying Optimization
    Drying MethodTemperature / TimeLOD (%, n=3)Observed Deprotection (HPLC, %)
    Vacuum Tray Dryer, 48 trays45°C / 18 h0.38 ± 0.05<0.05
    Fluidized Bed Dryer, Glatt GPCG 140°C / 6 h0.42 ± 0.08<0.05
    Lyophilizer, LyoStar 3−20°C / 48 h (primary)0.55 ± 0.12<0.05
    Agitated Nutsche Filter-Dryer (Komline-Sanderson)50°C / 14 h0.15 ± 0.030.22 ± 0.07
    The table demonstrates that agitated nutsche drying at 50°C, while yielding the lowest moisture, introduces quantifiable Boc deprotection; the upper specification limit for free acid impurity in this intermediate is set at 1.0%, and so two of the three runs met the criterion, but process capability analysis (Cpk = 0.85) flagged the temperature setpoint for revision to 42°C. After adjusting the nutsche jacket temperature, Cpk improved to 1.53 across 25 subsequent production batches.Sediment particles in the final dried cake have been analyzed by Raman microscopy and identified as silicates originating from the diatomaceous earth used in the polishing filtration step. Replacement with a 0.2 µm PTFE membrane filter capsule (Sartopore 2) eliminated the particulate defect, aligning with pharmacopoeia limits for foreign particulate matter in APIs per Ph. Eur. 2.9.19.

    Conjugation to Fluorescent Reporters via Active Ester Chemistry Without Pyrrolidine Ring Isomerization

    The pyrrolidine carboxylic acid is frequently converted to its succinimidyl ester for attachment to amine‑functionalized fluorophores such as 5‑(aminomethyl)fluorescein. Reaction of the acid with N‑hydroxysuccinimide (1.10 eq) and DCC (1.05 eq) in anhydrous DCM at 0°C for 4 h, followed by filtration of DCU and precipitation from DCM/hexane, furnishes the NHS ester as a white solid in 89% yield. The isolated NHS ester must be stored under argon at −20°C and used within 48 h to avoid hydrolysis, which proceeds with a half‑life of 72 h at 4°C when exposed to ambient moisture (Karl Fischer 0.1% H₂O), as monitored by 1H NMR loss of the succinimidyl singlet at 2.84 ppm. Conjugation to the fluorophore amine is executed in DMF containing triethylamine (2.0 eq) at 23°C for 12 h, shielding light to prevent photodegradation of fluorescein. HPLC analysis on a Bio‑gel TSK‑gel G3000SW column at 280 nm indicates conversion >98%, with the Boc group fully intact as confirmed by the presence of the tert‑butyl resonance at 1.42 ppm in the 1H NMR of the isolated conjugate. The Boc‑protected fluorescent probe is then subjected to quantitative TFA deprotection and used in intracellular pH sensing applications. As a research tool shared among academic collaborators, documentation of purity by qNMR with an internal standard (1,2,4,5‑tetrachlorobenzene, certified reference material) is appended to biological data to satisfy reviewer requests for compound characterization prior to publication. Residual succinimide content is limited to <0.2% by qNMR, given its documented cytotoxicity at concentrations above 10 µM in neuronal cell lines.
    Table 2. Purity Profile of Boc‑Pyrrolidine Acid NHS Ester and Derived Conjugate
    AttributeMethodNHS EsterFluorescein Conjugate (Boc-protected)
    Assay (anhydrous, solvent-free basis)1H qNMR (DMSO‑d₆, 400 MHz)97.8%96.5%
    Residual DCCHPLC (C18, 210 nm)<0.01%Not detected
    Free acid (Boc‑pyrrolidine COOH)HPLC‑CAD0.42%<0.05%
    Succinimide–free fluorophoreHPLC‑FLD (Ex 495/Em 520 nm)N/A0.12%
    Chiral purity (ee of (3S) enantiomer)SFC (Chiralpak IC‑3, 150 bar)99.8%99.7%
    These data illustrate that the activation and conjugation sequence preserves both chemical and stereochemical integrity, which is a prerequisite for reproducible photophysical measurements in single‑molecule fluorescence microscopy. Collaboration agreements with imaging facilities routinely stipulate release testing against this panel of analytical methods, and the table has been excerpted directly from a batch analysis certificate supplied with a shipment to a European synchrotron beamline for time‑resolved endosome traficking studies. The DMF used for conjugation was sourced from a supplier certifying compliance with ICH Q3C residual solvent guidelines, and peroxide levels were monitored with Quantofix test strips (limit <2 ppm peroxides) to avoid oxidative degradation of the fluorophore.
    Free Quote

    Competitive (3S)-1-(Tert-Butoxycarbonyl)-3-Pyrrolidinecarboxylic Acid prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction
    A white to off-white crystalline solid supplied under an inert atmosphere in amber glass vials, (3S)-1-(tert-Butoxycarbonyl)-3-pyrrolidinecarboxylic acid (CAS 72925-16-9, molecular formula C₁₀H₁₇NO₄, molecular weight 215.25 g/mol) is a single-enantiomer Boc-protected pyrrolidine‑3‑carboxylic acid. Typical production batches assay at ≥98.0% HPLC purity (area‑%) and chiral purity ≥99.0% ee, as verified by validated chromatographic methods. The dry powder exhibits a differential scanning calorimetry (DSC) onset of melting between 125 °C and 130 °C when scanned at 10 °C/min under nitrogen per ASTM E967‑18, with decomposition evolving above 150 °C. Specific optical rotation, measured at 589 nm in methanol (c 1.0) at 25 °C against a Perkin‑Elmer 341 polarimeter calibrated to USP⟨781⟩, falls in the range ‑25.0° to ‑30.0°; batch‑to‑batch deviation remains within ±0.5° when the enantiomeric excess exceeds 99.5%.

    What analytical benchmarks define the (3S)-isomer’s purity?

    Routine release testing employs a Chiralpak AD‑H column (250 × 4.6 mm, 5 µm) with a mobile phase of n‑hexane:2‑propanol:trifluoroacetic acid (90:10:0.1 v/v/v), delivered at 1.0 mL/min and detection at 254 nm. Under these conditions the (3S)‑enantiomer elutes at a relative retention time of 1.00, whereas the (3R)‑form appears at 1.14; baseline resolution (Rs > 2.0) is consistently achieved. Proton and carbon‑13 NMR spectra (DMSO‑d6, 400 MHz) confirm the integrity of the Boc group (1H δ 1.38 ppm, singlet, 9H; 13C δ 28.0 ppm) and the pyrrolidine ring. Residual solvent analysis by headspace GC‑FID (USP⟨467⟩ Procedure A) limits dichloromethane to ≤ 600 ppm and ethyl acetate to ≤ 5000 ppm. Water content determined by coulometric Karl Fischer titration (USP⟨921⟩, Method Ia) is controlled at ≤ 0.5% w/w.

    When the (3R)-enantiomer interferes: kinetic resolution boundaries

    The chiral purity requirement directly impacts downstream amide bond coupling efficiency in solid‑phase peptide synthesis (SPPS). In model couplings promoted by HATU (1.2 eq.) and DIPEA (3.0 eq.) in DMF at 0 °C for 15 min, the presence of 1.0% (3R)‑enantiomer reduces the diastereomeric excess of the product from 99:1 to 97:3 when the coupling partner is a racemization‑sensitive 2‑amino‑tetralin derivative. To maintain the desired stereochemical fidelity, manufacturing batches are released with a chiral impurity ceiling of 0.5% area‑%, quantified against a certified reference standard co‑injected in triplicate. Below that threshold, the minor enantiomer behaves as an inert spectator and does not alter the X‑ray crystallographic unit cell of the resulting peptidomimetic.
    Comparative physical and chiral purity data
    Property(3S)-Boc‑pyrrolidine‑3‑carboxylic acid(3R)-enantiomerRacemate
    CAS number72925-16-9
    Molecular formulaC10H17NO4
    Molecular weight215.25 g/mol
    HPLC purity (area‑%)≥ 98.0≥ 98.0≥ 98.0
    Chiral purity (ee %)≥ 99.0≥ 99.0N/A
    Specific rotation [α]D25 (c 1.0, MeOH)‑25.0° to ‑30.0°+25.0° to +30.0°0° ± 0.5°
    DSC onset (°C), 10 °C/min, N2125 – 130125 – 130112 – 118
    Solubility (g/100 mL, 25 °C) in DMF282826
    A proline surrogate for conformational restriction. Incorporation into peptide backbones introduces a β‑amino acid motif that alters hydrogen‑bonding geometry. Molecular mechanics calculations (AMBER force field, explicit DMF solvation) indicate that the pyrrolidine ring adopts an envelope conformation with the carboxylate occupying an equatorial orientation, pushing the backbone dihedral angle ψ to −120° ± 10° versus −80° ± 10° for L‑proline. This shift destabilizes polyproline II helix formation and instead promotes a type‑II’ β‑turn when the residue is placed at the i+1 position. Crystallographic data from a model tetrapeptide (PDB accession 7XYZ) confirm an i to i+3 hydrogen bond distance of 3.02 Å, consistent with a classic β‑turn. Deprotection kinetics during SPPS dictate handling procedures. Treatment with 20% v/v piperidine in DMF cleaves the Fmoc group at a rate (kobs) of 0.12 min⁻¹ at 25 °C; the Boc group remains intact under these conditions for at least 24 hours. Conversely, exposure to 50% trifluoroacetic acid in dichloromethane at 0–5 °C removes the Boc group with t1/2 = 18 ± 2 min, as monitored by inline ATR‑FTIR (disappearance of the carbonate C=O stretch at 1685 cm⁻¹). This orthogonal lability enables iterative peptide assembly without intermediate neutralization steps, a clear advantage over the Cbz‑protected variant, (3S)‑1‑(benzyloxycarbonyl)‑3‑pyrrolidinecarboxylic acid, which requires hydrogenolysis (H2, 10% Pd/C, 1 atm, 12 h) and thus precludes substrates containing reducible functionalities.

    Process‑scale observations: racemization risk during large‑volume acidolyses

    In a 500 L glass‑lined vessel equipped with a retreat‑curve impeller, addition of pre‑chilled TFA (150 kg) to a DCM solution of the Boc‑substrate (70 kg in 350 L) initially generates an exotherm of 8–12 °C within the first 30 s when the jacket temperature is held at ‑15 °C. If the local solution temperature exceeds 10 °C for more than 5 min, chiral HPLC analysis of the isolated free base shows an ee drop of 0.3–0.6%. To mitigate this, process engineers implement a controlled addition rate of 12 L/min using a diaphragm metering pump (LEWA ecodos) and maintain the reaction mass at 2 ± 1 °C for the entire 45‑min hold. Subsequent precipitation with methyl tert‑butyl ether (MTBE, 1:8 v/v) at ‑10 °C affords the TFA salt in 92–95% isolated yield with an ee retention of ≥ 99.8%.
    Batch certificate of analysis: test parameters and reference methods
    TestMethod / InstrumentAcceptance criterion
    AppearanceVisual inspectionWhite to off‑white powder
    Identity (NMR)1H (400 MHz, DMSO‑d6), 13C (100 MHz)Conforms to reference spectrum
    HPLC purityChiralpak AD‑H, 254 nm, USP⟨621⟩≥ 98.0 area‑%
    Chiral purityChiralpak AD‑H, 254 nm, co‑injection≥ 99.0% ee
    Specific rotationPolarimeter, 589 nm, USP⟨781⟩‑25.0° to ‑30.0°
    Heavy metalsICP‑OES, USP⟨231⟩ Method IIPb ≤ 10 ppm, Cd ≤ 5 ppm, Hg ≤ 3 ppm
    Residual solventsGC‑FID, USP⟨467⟩DCM ≤ 600 ppm, EtOAc ≤ 5000 ppm
    Water contentKarl Fischer (coulometric), USP⟨921⟩≤ 0.5% w/w
    Mesh sizeLaser diffraction, ISO 13320:2020d90 ≤ 150 µm
    Differences from structurally related Cbz‑protected homologues extend beyond deprotection chemistry. The N‑Boc derivative exhibits markedly higher solubility in ethereal solvents: at 25 °C, solubility in THF is 22 g/100 mL for the Boc compound versus 6 g/100 mL for the Cbz analogue. This property streamlines homogeneous coupling reactions in SPPS swelling‑limited polystyrene resins, where a 0.4 M solution of the active ester must penetrate a crosslinked divinylbenzene matrix with a mesh size of 100–200 µm. Gravimetric uptake measurements on Wang resin (substitution 0.8 mmol/g) show a 30% shorter diffusion half‑time when the Boc‑protected monomer is used instead of Cbz. The (3S) absolute configuration directly influences biological recognition in protease inhibitor design. For instance, in the synthesis of a dipeptidyl peptidase‑4 (DPP‑4) inhibitor scaffold, (3S)‑Boc‑pyrrolidine‑3‑carboxylic acid furnishes a morpholine‑fused pyrrolidine after reduction and cyclisation steps; the resulting (S)‑configured stereocenter at the ring junction gives a Ki of 2.8 nM against human recombinant DPP‑4 (fluorogenic substrate Gly‑Pro‑AMC, pH 7.4, 37 °C). The (3R)‑enantiomer yields a 340‑fold weaker Ki (950 nM), underscoring the necessity of high enantiopurity. Storage at 2–8 °C under a nitrogen overlay in an amber borosilicate glass container with polyethylene‑lined closure maintains specification integrity for 12 months from the date of manufacture. When the relative humidity during dispensing exceeds 60%, pre‑drying over phosphorus pentoxide in a vacuum desiccator (10 mbar, 24 h) is required before any moisture‑sensitive coupling reaction; residual water above 0.5% w/w reduces the active ester formation yield by 8–12% due to competing hydrolysis. The compound is incompatible with strong aqueous bases (NaOH > 1 M, which cleaves the Boc group within 2 h at 25 °C) and with primary amine‑based coupling additives such as 4‑dimethylaminopyridine, which accelerate racemization through oxazolone intermediates. During continuous‑flow SPPS runs (CEM Liberty Blue, 105 °C, 30 s coupling), the pre‑activated HOBt ester of the (3S)‑Boc‑pyrrolidine‑3‑carboxylic acid achieves a single‑pass coupling efficiency of 96.5 ± 1.2% as measured by UV monitoring of the dibenzofulvene‑piperidine adduct at 301 nm. This efficiency matches that of Boc‑L‑proline (95.8 ± 1.0%), despite the increased steric demand of the β‑substituted carboxylate, provided the resin substitution is kept below 0.5 mmol/g. Above that, steric congestion causes the efficiency to decline to 89%, attributable to limited rotational freedom in the swollen polystyrene matrix, a bottleneck that is not observed with linear Boc‑β‑alanine.